Good Summary Thadius, thanksI'll happily take 60mt clearing $20/t with low CAPEX if they can pull that off. That's still $1.2 Billion total, very good indeed!!!
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress